ClinicalTrials.gg
Enrolling by invitationNCT07478861RCTUpdated Oct 2, 2026

Whole-body Vibration Training on the Elderly With Combined Bilateral Knee Osteoarthritis

An interventional study of Whole-body vibration training in Knee OA, Sarcopenic Obesity and Whole Body Vibration, sponsored by Beni-Suef University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 60 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 2, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.

Planned enrollment
76th of 83
30 · median 62
Started
2026
with 14 others
No phase
76 of 91
22 open now
Primary completion
2027-02
later than 24 of 33 live
Registered
77th of 91
by date

Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 76th largest by planned enrollment of the 83 interventional ones that give a count, is one of 15 that started in 2026, is one of 76 with no phase, reaches primary completion later than 24 of the 33 other live ones, and was the 77th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 60 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Osteoarthritis, Knee with a site in Egypt, or all of them as a file.
02

Study summary

This study will aim to evaluate the effects of whole-body vibration training (WBVT) on body composition, muscle strength (hand grip strength), and physical performance [gait speed (GS), 5-time chair stand test (5CST), and short physical performance battery (SPPB), pain intensity, triglycerides in older people with knee OA and sarcopenic obesity in a group of Men compared to group of females.

Read the detailed description

Both groups received the intervention 3 times a week for 12 weeks. WBVT group. Each intervention lasted 30 min, which included 5 min of warm-up, 20 min of vibration training, and 5 min of relaxation.

03

Conditions studied

  • Knee OA
  • Sarcopenic Obesity
  • Whole Body Vibration

Keywords

  • knee osteoarthritis
  • elderly patients
  • sarcopenic obesity
  • whole body vibration training
04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with KOA were graded based on the Kellgren-Lawrence grading criteria (K-L grading)
  • only grades 3 and 4 will be included in this study
  • Sarcopenia obesity based on with SMI with SMI \< 7 kg/m2
  • PBF ≥ 30% into the SO group
  • ≥ 28%, or waist circumference ≥ 85 cm in men and ≥ 80 cm in women
  • able to communicate

Exclusion criteria

Exclusion Criteria:

  • Inability to walk
  • Knee joint underwent drug treatment or intra-articular injection
  • Uncontrollable angina pectoris induced by exercise
  • Uncontrolled hypertension, acute or chronic renal failure, or dyspnea in the resting state
  • Neurological or respiratory conditions or injuries (ie, dementia, Alzheimer's disease, multiple sclerosis, ), rheumatoid arthritis and clinical depression.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Elderly male patients with knee osteoarthritis

    Elderly male patients with knee osteoarthritis associated with sarcopenic obesity

    Other: Whole-body vibration training

  • Active comparator
    Elderly female patients with knee osteoarthritis

    Elderly female patients with knee osteoarthritis associated with sacropenic obesity

    Other: Whole-body vibration training

Interventions

  • OtherWhole-body vibration training

    Whole-body vibration therapy stimulates muscle contraction. It can increase muscle function to a level like that of classical resistance training, but with the advantage of being more convenient and safer

06

What researchers measure

Primary outcomes

  1. Physical performance

    These are standardized tests used to assess lower limb strength, mobility, and overall functional ability in elderly patients it includes: 1. Gait speed (it is the rate a person can tolerate walking measured in meter per seconds (ask the person to walk at their usual comfortable pace for 10 meters; and record how many seconds it takes to complete this distance and evaluate the recorded time before and after the treatment); 2. 5-time chair stand test; t evaluates how quickly a participant can perform 5 successive sit-to-stand without using their arms (it evaluate the time taken to complete 5 repetitions, a. ≤ 12 seconds is considered normal physical performance, b. \> 15 seconds may indicate lower extremity weakness, mobility limitations, or increased fall risk, c. Unable to complete indicates significant functional impairment). All measurements will be carried out before the treatment and after the end of the treatment.

    Time frame: 8 weeks

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 3 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 2, 2026: start Mar 2026 → Nov 2026, primary completion Jun 2026 → Feb 2027 and completion Jul 2026 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2026
First posted
Mar 18, 2026
StartEst.
Nov 15, 2026was Mar 2026
Primary completionEst.
Feb 15, 2027was Jun 2026
CompletionEst.
Apr 15, 2027was Jul 2026
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Mar 15, 2026→Nov 15, 2026
Oct 2, 2026
Primary completion
Jun 30, 2026→Feb 15, 2027
Oct 2, 2026
Study completion
Jul 1, 2026→Apr 15, 2027
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Start date Mar 15, 2026→Nov 15, 2026
    Primary completion Jun 30, 2026→Feb 15, 2027
    Study completion Jul 1, 2026→Apr 15, 2027
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07478861
Responsible party
Mariam Abdel Rahman (Lecturer of Orthopaedic Physical Therapy, Beni-Suef University) — Principal investigator
First posted
Mar 18, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Feb 15, 2027 (estimated)
Completion
Apr 15, 2027 (estimated)
Last update
Oct 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion